Data Reliability - Internet

Similar documents
ALCOA AND DATA INTEGRITY: PASTAND FUTURE

21 CFR Part 11 Compliance for SaaS/Cloud Applications

Reduce costs for compliance with data integrity: 21 CFR Part 11, SaaS/Cloud, EU GDPR

Considerations for Using etools in Research: Part 11 and System Validation

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011

Data Integrity Why is it important? DADM Conference - 22 August 2017

GxP Auditing, Remediation, and Quality System Resourcing

GxP Auditing, Remediation, and Staff Augmentation

ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER TUUSULA FINLAND. Timo Kuosmanen STERIS Finn-Aqua

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

[ WHITE PAPER ] A Basic Overview: Meeting the PIC/S Requirements for a Computerized System INTRODUCTION GOOD MANUFACTURING PRACTICES

EU Annex 11 US FDA , (g), (i), 11 Orlando López 09-APR

DATA INTEGRITY IN CLINICAL RESEARCH. Singapore Clinical Research Professional (CRP) Forum 25 August 2017

Introduction to 21 CFR 11 - Good Electronic Records Management

GxP Auditing, Remediation, and Staff Augmentation

DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS

Library Guide: Active Pharmaceutical

Inspection Trends. American Society for Quality Richmond, VA Section March 8, 2016

A Comprehensive Approach to Find and Remediate Data Integrity Problems

EU and FDA GMP Regulations: Overview and Comparison

Global Compliance Trends and Warning Letters

Applicability of US Regulations to Canadian Research

GCP Basics - refresher

Clarity CDS since version 7.2 supportive tools for compliance with Title 21 CFR Part 11, EudraLex Chapter 4, Annex 11 and other similar legislation

Could Poor Temperature Data Management be Putting Your GxP Facility at Risk for Data Integrity Violations? we prove it.

Compliance & Validation Validation of Software-as-a-Service (SaaS Solutions)

Electronic Records and Electronic Signatures (21 CFR Part 11)

New Data Integrity Regulations and Practical Advice for Life Science Laboratories. we prove it.

Lessons from Pharmaceutical Laboratory related FDA Warning Letters

ISPE-FDA 3 rd Annual CGMP Conference 2 4 June 2014 Baltimore, MD. Detecting GMP Data Integrity Issues

Data Integrity in GXPs

Payment Card Industry Data Security Standard Compliance: Key Players and Relationships. By Jason Chan

Regulatory Visits, Audits and Investigations

Understanding GxP Regulations for Healthcare

Regulations in Pharmaceutical Laboratories

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

Good Documentation Practices. Documentation Requirements For Regulated Environments

21CFR11 Compliance and Automated Manufacturing

DATA ON THE MOVE = BUSINESS ON THE MOVE

Ensure Data Integrity Compliance Enterprise-Wide

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11.

SIMATIC IT. SIMATIC IT R&D SUITE V7.1 Compliance Response ERES. Introduction 1. The Requirements in Short 2

CRITICAL OF CHOOSING THE SOLUTION

Standard Statement and Purpose

The Role of the LMS in 21 CFR Part 11 Compliance

How to support compliance with GAMP 5

Information Security in ITES & BPO I T S E R V I C E S B P O S O L U T I O N S

How to support compliance with GAMP 5

10 "Must-Haves" for the Life Sciences Learning Management System

GMP Track 1 Day 2 Session 1 Vendor Assurance

Pharmaceutical cgmps for the 21st Century February 2004

Atlant s atwatch CAPA TM. Corrective and Preventive Action System (CAPA) Product & Services Bundle for

KINGSMANN CARE GROUP

WHO SAYS COMPLIANCE NEEDS TO BE COMPLICATED?

Data Integrity Trends and How They Impact Validation. Erik Muegge, M.S., PMP Abbott Diagnostics Division IVT Dublin Validation Week 2016

LEGAL REQUIREMENTS and DATA INTEGRITY...

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario

IMPLEMENTATION OF THE EU FALSIFIED MEDICINES DIRECTIVE, 2011/62/EU. IPA/EDQM/WHO 2012, Mumbai

Demystify Governance, Risk & Compliance For Lifesciences

Managing Legal and Operational Risk in IT Agreements

Life Sciences Courseware. Knowledge. Performance. Impact.

Good Clinical Practice (GCP): how does a laboratory that supports a clinical trial ensure compliance with these Regulations

Effective Management and Operations of GXP Laboratories

COMPUTERIZED SYSTEM VALIDATION

Serving Patients is a Privilege

Regulatory Overview Annex 11 and Part 11. Sion Wyn Conformity +[44] (0)

Data Integrity Through the Life Cycle Balancing Quality and Innovation. Sion Wyn Conformity +44 (0)

Quo Vadis 21 CFR 11. R.D. McDowall, McDowall Consulting, Bromley, Kent, UK.

LEVERAGING YOUR VENDORS TO SUPPORT DATA INTEGRITY:

Risk-based Approach to Part 11 and GxP Compliance

Data Integrity: Identifying and Resolving the Issues. Gary Bird, Ph.D. Vice President, Regulatory Affairs and Quality

Preparing for Successful Data Integrity Audits. Mary Chris Easterly & Richard D. Schlabach 13 October 2017

Addressing the Paradigm Shift in Regulatory Inspections

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals

Welcome. Data Integrity Beyond Bytes and Signatures. Paul Daniel Senior Regulatory Compliance Expert

Jean Guichard. Introduction to Good Process Record Management (GxP) #: Internet-WP Version: e1.00 /EN

Chapter 1. Pharmaceutical Industry Overview

Computer System Validation - Reduce Costs and Avoid 483s

Facilitating Compliance with 21 CFR Part 11

R. Scott Murchison, CRM Kaizen InfoSource LLC SVP, Information Management Services

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev19Dec14

Securing Intel s External Online Presence

Information Governance for Data Integrity

ARCHIVING REGULATIONS

please fill out here:

Supplier Oversight PQRI. September Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan

Conducted Under an IND to Support a

Documenta tion and Records

Internationally harmonised requirements for batch certification

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009

GMP GUIDELINES. GMP Guides from Industry Organisations. FDA cgmp WHO GMP. cgmp Guide Drugs 21 CFR 210 GAMP. ISPE Technical Guides

While the recognition

Sarbanes-Oxley Compliance Kit

Source Documents Elettronici: Criticità Applicative e approccio alla convalida. Paolo Morelli CEO - Arithmos

Regulatory Expectations, Standards & Guidelines

Christian Gausepohl, Frank Böttcher. GMP Focus. Managing Contract Manufacturers and Testing Labs. PDF Download. Excerpt from the GMP MANUAL

Data Integrity. Requirements for a GMP-compliant Data Life Cycle SPEAKERS: August 2017, Copenhagen, Denmark LEARNING OBJECTIVES:

Company Name and Corporate Structure (LLC, B-Corp, C-Corp, etc.): Company Category: Company Size and Stage of Development:

Traceability of Autologous Drug Product from Cell Procurement through Infusion

Transcription:

Data Reliability - Internet Wikipedia https://en.wikipedia.org/wiki/reliability_of_wikipedia Others http://www.dailymail.co.uk/health/article- 2639910/Do-NOT-try-diagnose-Wikipedia-90-medicalentries-inaccurate-say-expertsDo.html http://www.dailymail.co.uk/sciencetech/article- 2131458/Up-articles-Wikipedia-contain-factualerrors.html http://www.foxbusiness.com/features/2015/09/02/ju st-how-accurate-is-wikipedia.html

DATA INTEGRITY AND DATA MANAGEMENT FOR GXP REGULATED FIRMS John M. Lewis Friday, May 13, 2016

Training Disclaimer This document is an overview training document and is provided "as is", to be used as a reference only. Use of this document for any purposes other than as reference material (i.e., for the purposes of training and testing users on data related items by other commercial entities or individuals) is not advised. In no event shall the authors and or presenter of this material, be liable for any claim, damages, or other liability whether in action or contract, arising from, out of, or in connection with the use of the information in this document for training, testing, or ongoing safe and compliant use of data. Please consult your own lawyers and subject matter experts if you are looking to develop your own data integrity and data management curriculum. Data users are responsible for their knowledge, skills and ability, including reading and understanding applicable regulations, guidelines and standards.

Welcome

Today s Overview 1 Familiarize yourself with Data (Integrity & Management) 2 Understand Your role

Data & Data Systems Working Toward Mastery Achieve Mastery Get Experienced Get Familiar Time Spent

Data facts and statistics collected together for reference or analysis. Computing the quantities, characters, or symbols on which operations are performed by a computer, being stored and transmitted in the form of electrical signals and recorded on magnetic, optical, or mechanical recording media.

Data Continuum Personal Finance GCP GLP GMP MEDICAL RECORDS LEGAL RECORDS STOCK MARKET CLINICAL TRIAL SPECIFICATIONS EQUIPMENT VALIDATION IQ/OQ/PQ BANKING FORMS TEST RESULTS BATCH RECORD PAYROLL PRODUCT RELEASE

Data Integrity Data integrity is the assurance that data records are accurate, complete, intact and maintained within their original context, including their relationship to other data records. Ensuring data integrity means protecting original data from accidental or intentional modification, falsification or even deletion, which is the key to reliable and trustworthy records that will withstand scrutiny during regulatory inspections.

DATA STANDARDS - ALCOA Data Management

Data Management Data management is the development and execution of architectures, policies, practices and procedures in order to manage the information lifecycle needs of an enterprise in an effective manner.

Your Role in Ensuring Data Integrity

Mandates to Manage Data The generics scandal of the 1980 s raised the issue of falsified data submitted to FDA in support of drug approvals. One outcome of this scandal was the shift in focus of the FDA pre-approval inspection (PAI) to evaluate raw laboratory data included in the marketing application and evaluate whether the site was capable of manufacture as described in the application. This scandal also prompted implementation of the Application Integrity Policy in 1991 which describes the Agency's approach regarding the review of applications that may be affected by wrongful acts that raise significant questions regarding data reliability. Five firms are on the current CDER Application Integrity Policy List effective October 1, 2015.

Data Management

DATA INTEGITY REGULATIONS Broad Laws Sarbanes-Oxley Act (SOX); Payment Card Industry Data Security Standard (PCI DSS); Gramm-Leach-Bliley Act (GLB) Act; Electronic Fund Transfer Act, Regulation E (EFTA); Customs-Trade Partnership Against Terrorism (C-TPAT); Free and Secure Trade Program (FAST); Children's Online Privacy Protection Act (COPPA); Fair and Accurate Credit Transaction Act (FACTA), including Red Flags Rule; Federal Rules of Civil Procedure (FRCP) Industry Specific Guidelines & Requirements Federal Information Security Management Act (FISMA); North American Electric Reliability Corp. (NERC) standards; Title 21 of the Code of Federal Regulations (21 CFR Part 11) Electronic Records; Health Insurance Portability and Accountability Act (HIPAA); The Health Information Technology for Economic and Clinical Health Act (HITECH); Patient Safety and Quality Improvement Act (PSQIA, Patient Safety Rule); H.R. 2868: The Chemical Facility Anti-Terrorism Standards Regulation

DATA INTEGITY REGULATIONS FDA inspects for electronic data integrity during the preand post market product approval process under 21 CFR Part 11, which is commonly referred to as the data integrity regulation. When FDA published its intent to raise the enforcement profile of 21 CFR 11 (Part 11) in 2010, it listed four goals: 1. Assess the industry s comprehension or continuing misinterpretations of Part 11. 2. Determine how firms are ensuring the integrity of electronic records. 3. Extend scrutiny of data, quality-related and computerized system validation-related Form 483 inspectional observations since 2007. 4. Determine next steps for Part 11, including whether to issue a revised regulation or simply draft more guidance.

DATA INTEGITY REGULATIONS The General Data Protection Regulation (GDPR) is a Regulation by which the European Commission intends to strengthen and unify data protection for individuals within the European Union (EU). It also addresses export of personal data outside the EU. The three main cybersecurity regulations are the 1996 Health Insurance Portability and Accountability Act (HIPAA), the 1999 Gramm-Leach-Bliley Act, and the 2002 Homeland Security Act, which included the Federal Information Security Management Act (FISMA).

GDPR: Businesses that fail to comply with the regulation... can be fined up to $20 million, or 4 percent of global revenues. That s huge. Here s what a hypothetical fine could look like for just a handful of well-known, global brands based on total revenues for 2014: Twitter: $56 million General Mills: $716 million Goodyear: $725 million Vodafone: $2.3 billion HP: $4.5 billion Apple $9.3 billion

Case Study Jimmy works for a small BioBest Company His first day he learns: SOP System is not version controlled Clinical Protocols have multiple uncontrolled versions in use Batch Records are missing data and have errors recorded Lab testing results recorded have been found to be altered Product release is missing signatures

Discussion What we can learn from Jimmy Best practices Take-aways

Characteristics of Trustworthy Records National Archives & Records Administration Reliability: trusted to be complete & accurate Authenticity: proven to be what it purports to be Integrity: complete and unaltered Usability: can be located, retrieved, presented & interpreted.

Review 1 Familiarize yourself with Data (Integrity & Management) 2 Understand Your role

References FDA 21 CFR Part 11, Electronic Records; Electronic Signatures, 1997 Preamble to the final rule, 21 CFR Part 11, March 20, 2997 Guidance for Industry, General Principles of Software Validation, January, 2002 FDA 21 CFR Part 211. Current Good Manufacturing Practice for Finished Pharmaceuticals. FDA Compliance Program Guidance Manual, Chapter 46 New Drug Evaluation, Pre-Approval Inspections, Program 7346.832 FDA slide deck describing GMP audits of Data Integrity and Automated Systems. This presentation was given by Robert D. Tollefsen National Expert Computers on April 27, 2010. He delivered the same slide deck at many industry conferences. FDA Guidance for Industry, Part 11, Electronic Records; Electronic Signatures Scope and Application, 2003 FDA Guidance for Industry, Electronic Source Data in Clinical Investigations, September 2013 formally addresses the ALCOA acronym. 15-page form 483 issued to Able Laboratories in 2005. Rules Governing Medicinal Products in the European Union. Good Manufacturing Practice, Annex 11, Computerized Systems, effective 30 June 2011 Rules Governing Medicinal Products in the European Union, Good Manufacturing Practice, Part II: Basic Requirements for Active Substances Used as Starting Materials MHRA GMP Data Integrity Definitions and Guidance for Industry, March 2015 MHRA expectations regarding self inspection and data integrity, December 2013. See also the explanation from the European Compliance Academy HERE. MHRA Inspectorate Blog on Data Integrity, 3 parts starting June 25, 2015. MHRA Presentation on Data Integrity in Goa, India, September 2014. See the link to download the slides at the bottom of the page. ICH Q7, Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients PIC/S Guidance, Good Practices for Computerized Systems in Regulated GXP Environments, 25 Sept 2007. Guidance for Inspectors, PI 011-3 PIC/S Annexes to GMP Guide, Annex 11, Computerized Systems in the GMP Guide (Annexes) WHO published a 35-page draft document on their website for comment, Guidance on Good Data and Record Management Practices for GXP regulated activities. WHO Notice of Concern issued to Quest Life Sciences Pvt. Ltd on 30 June 2015. This site conducts clinical studies WHO Notice of Concern issued to Svizera Labs Private Limited on 2 September 2015. Addressing the historical issue of data integrity in FDA enforcement actions: The Financial Value of a Comprehensive GMP Regulatory Intelligence Program, March 25, 2015, Unger Consulting, Inc., includes links to associated warning letters, particularly those from 2000-2008. Notre Dame Law Review, Volume 75, Issue 1, October 1, 1999, page 312. Describes the nature and outcome the US generic drug scandal. Unger Consulting Inc. data, available upon request. Delineates the common regulations cited in FDA warning letters associated with data integrity.

QUESTIONS?